Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31476 - 31500 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	CARS	833	downregulated	Cisplatin results in decreased expression of CARS mRNA	11p15.4	A20427
Cisplatin	Approved Investigational	CASP3	836	upregulated	Cisplatin results in increased expression of CASP3 mRNA	4q35.1	A22229 A22236 A22219
Cisplatin	Approved Investigational	CASP7	840	upregulated	Cisplatin results in increased expression of CASP7 mRNA	10q25.3	A22237
Cisplatin	Approved Investigational	CASP8	841	upregulated	Cisplatin results in increased expression of CASP8 mRNA	2q33.1	A22238
Cisplatin	Approved Investigational	CASP9	842	downregulated	Cisplatin results in decreased expression of CASP9 mRNA	1p36.21	A22196
Cisplatin	Approved Investigational	CASP9	842	upregulated	Cisplatin results in increased expression of CASP9 mRNA	1p36.21	A22219
Cisplatin	Approved Investigational	CCDC51	79714	downregulated	Cisplatin results in decreased expression of CCDC51 mRNA	3p21.31	A21499
Cisplatin	Approved Investigational	CCDC90B	60492	downregulated	Cisplatin results in decreased expression of CCDC90B mRNA	11q14.1	A20427
Cisplatin	Approved Investigational	CCNE2	9134	upregulated	Cisplatin results in increased expression of CCNE2 mRNA	8q22.1	A20427
Cisplatin	Approved Investigational	CCNG2	901	downregulated	Cisplatin results in decreased expression of CCNG2 mRNA	4q21.1	A20427
Cisplatin	Approved Investigational	CCNK	8812	upregulated	Cisplatin results in increased expression of CCNK mRNA	14q32.2	A22205
Cisplatin	Approved Investigational	CCNY	219771	downregulated	Cisplatin results in decreased expression of CCNY mRNA	10p11.21	A22204
Cisplatin	Approved Investigational	CDC25A	993	downregulated	Cisplatin results in decreased expression of CDC25A mRNA	3p21.31	A21499
Cisplatin	Approved Investigational	CDC42	998	upregulated	Cisplatin results in increased expression of CDC42 mRNA	1p36.12	A22205
Cisplatin	Approved Investigational	CDC6	990	downregulated	Cisplatin results in decreased expression of CDC6 mRNA	17q21.2	A21499
Cisplatin	Approved Investigational	CDH1	999	downregulated	Cisplatin results in decreased expression of CDH1 mRNA	16q22.1	A22239
Cisplatin	Approved Investigational	CDK1	983	downregulated	Cisplatin results in decreased expression of CDK1 mRNA	10q21.2	A22211
Cisplatin	Approved Investigational	CDK2AP1	8099	upregulated	Cisplatin results in increased expression of CDK2AP1 mRNA	12q24.31	A22204
Cisplatin	Approved Investigational	CDK2AP2	10263	upregulated	Cisplatin results in increased expression of CDK2AP2 mRNA	11q13.2	A22204
Cisplatin	Approved Investigational	CDK6	1021	downregulated	Cisplatin results in decreased expression of CDK6 mRNA	7q21.2	A22240 A20427
Cisplatin	Approved Investigational	CDKAL1	54901	downregulated	Cisplatin results in decreased expression of CDKAL1 mRNA	6p22.3	A22203
Cisplatin	Approved Investigational	CDKN1A	1026	upregulated	Cisplatin results in increased expression of CDKN1A mRNA	6p21.2	A22210 A22241 A22204 A22214 A22212 A22242 A21499 A22205 A20427
Cisplatin	Approved Investigational	CDKN1B	1027	upregulated	Cisplatin results in increased expression of CDKN1B mRNA	12p13.1	A22226
Cisplatin	Approved Investigational	CDKN2A	1029	upregulated	Cisplatin results in increased expression of CDKN2A mRNA	9p21.3	A22243
Cisplatin	Approved Investigational	CEBPD	1052	upregulated	Cisplatin results in increased expression of CEBPD mRNA	8q11.21	A22204

Displaying entries 31476 - 31500 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability